Diffuse type brainstem glioma is one of the most malignant types of brain tumors and the prognosis is extremely poor. The proliferative potential of these tumors is presumed to be very high, but there is little information about the cell kinetics of brainstem glioma because surgical resection is rarely performed. The histological grade, tumor spread, growth potential, and prognosis were evaluated in 40 autopsy cases of diffuse type brainstem glioma. To quantify the growth potentials of individual tumors, the proliferating cell indices of Ki-67 (MIB-1) and proliferating cell nuclear antigen (PCNA) monoclonal antibodies were measured. Mean MIB-1 and PCNA proliferating cell indices were 20.4% (24 cases) and 37.0% (28 cases), respectively, in 34 glioblastomas. The median survival time was 40 weeks in 22 treated patients. The mean PCNA proliferating cell index was 10.8% in four of five anaplastic astrocytomas and the median survival time in four treated patients was 91 weeks. The MIB-1 and PCNA proliferating cell indices of one astrocytoma were 2.9% and 20.3%, respectively, and the survival time was 56 weeks. The overall median survival time was 32 weeks. There was a significant difference in PCNA proliferating cell indices between glioblastomas and anaplastic astrocytomas (p º 0.05) and there was a significant difference in survival time between glioblastomas (40 weeks) and anaplastic astrocytomas plus astrocytoma (74 weeks) among the treated patients (p º 0.05). Supratentorial extension was more frequent in glioblastomas than in anaplastic astrocytomas (p º 0.05). Our results suggest that the majority of diffuse type brainstem gliomas are glioblastoma and the proliferative potential is probably as high as that of adult supratentorial glioblastoma. Supratentorial extension and dissemination are relatively frequent in the advanced stage. Anaplastic astrocytoma or astrocytoma is rarer and less infiltrative and proliferative, and carries a slightly better prognosis than glioblastoma.
Introduction
Brainstem gliomas account for approximately 10-20% of all pediatric brain tumors. 1, 12, 14) Poorly demarcated and diffusely infiltrating gliomas, that is`d iffuse type'' brainstem gliomas 4, 8, 13, 25) or so-called`p ontine glioma,'' are thought to be biologically malignant irrespective of their histological gradings. Autopsy studies 6, 7, 20, 22, 23, 32, 33) have revealed that a substantial proportion of diffuse type brainstem gliomas were malignant, but the extent of tumor spread to the cerebrum, cerebellum, and spinal cord is unclear. 22) The poor prognosis of these tumors indicates high proliferative potentials, but the cell kinetics of the brainstem gliomas are unknown because surgical resection of these tumors is rarely performed. However, the indices of tumor cell proliferation correlate fairly well with the prognosis for individual patients with gliomas. Immunohistochemical studies with the thymidine analog bromodeoxyuridine (BrdUrd) have shown that a high BrdUrd labeling index, or S-phase fraction, indicates a higher proliferative potential, greater biological malignancy, and shorter time to recurrence. [15] [16] [17] 26) Some proliferation-associated nuclear proteins, such as Ki-67 protein and proliferating cell nuclear antigen (PCNA), are also useful for quantifying growth potential. 9, 10, 19, 24, 34) Recently, close correlations have been found between MIB-1 (a monoclonal antibody for Ki-67 protein) or PCNA proliferating cell indices and the biological malignancy of various types of brain tumors, including J. Yoshimura et al.
supratentorial gliomas. Antibodies to these indicators are suitable for use in formalin-fixed paraffinembedded tissues.
The present study examined the histological features, tumor spread, and proliferative potential, as measured by MIB-1 and PCNA monoclonal antibodies, in 40 autopsy cases of diffuse type brainstem gliomas to evaluate the relationship with the prognosis.
Materials and Methods

I. Patients
A total of 72 patients with brainstem glioma which was verified by autopsy, biopsy, and/or neuroimaging were admitted to Niigata University Hospital between January 1962 and December 1996. Patients with tumor arising primarily within the midbrain were excluded. Sixty-four cases were the diffuse type 25) and the other eight cases were the localized type. 25) The majority of these patients had already died and some had undergone autopsy. Forty autopsy specimens which were thought to be the diffuse type based on clinical and histological findings were available for this study, obtained from 22 males and 18 females aged 3 to 46 years (mean 12.6 years) at admission. Most patients had received radiotherapy and chemotherapy, and some had undergone surgical intervention. The clinical data are summarized in Table 1 .
II. Histological examination
Systemic autopsies including the whole spinal cord were performed in 16 cases and autopsy of the intracranial tissues including the upper cervical cord in 24 cases. The autopsy specimens were fixed in 10% formalin or 4% paraformaldehyde for 2 to 4 weeks. After fixation, the cerebrum was cut serially into 10-mm thick blocks, and the brainstem and cerebellum into 5-mm thick blocks. The spinal cord was cut into approximately 10-mm thick blocks at the upper cervical (C1-2), lower cervical (C6-7), thoracic (T7-8), and lumbar portions (L3-4). Representative parts of the tumor, cerebrum, cerebellum, brainstem, and spinal cord were embedded in paraffin. Each block was serially sectioned into 4-mm thick slices and used for hematoxylin and eosin, Kl äuver-Barrera, and immunohistochemical staining. The histology was classified according to the World Health Organization classification. 18) Heterogeneous tumors were classified as the higher histological grade. Parenchymal and leptomeningeal spread was evaluated microscopically in all sections of the tumor, cerebrum, brainstem, cerebellum, and spinal cord.
III. Immunohistochemistry of Ki-67 (MIB-1) and PCNA Thirty-eight specimens were available for immunohistochemical studies. A representative part of the tumor was serially sectioned and used for MIB-1 and PCNA studies. Each section was deparaffinized, placed in 10 mM citrate buffer (pH 6.0), and heated at 939 C for 15 minutes in a commercial microwave. 35) The sections were placed in 0.3% H 2 O 2 in methanol for inhibition of endogenous peroxidase for 30 minutes, then reacted with normal horse serum for 10 minutes and with the following primary antibodies at 49 C overnight: MIB-1 (Immunotech S.A., Marseilles, France) diluted 1:100 in phosphatebuffered saline (PBS) containing 0.05% Tween 20 and PCNA (Dakopatts, Glostrup, Denmark) diluted 1:100 in PBS. The sections were washed in PBS for three times and were reacted with biotinylated horse anti-mouse immunoglobulin G for 60 minutes. The sections finally were reacted with avidin biotin peroxidase complex (ABC) with a Vectastain ABC kit (Vector, Burlingame, Calif., U.S.A.) for 60 minutes, developed with diaminobenzidine, and counterstained with hematoxylin. The MIB-1 and PCNA proliferating cell indices were calculated as the percentage of immunostained nuclei, excluding the nuclei of vascular components and hematogenous cells. More than 1000 cells were counted in several areas of tissue in which positive nuclei were evenly distributed. The most actively proliferating areas were examined to measure the MIB-1 and PCNA proliferating cell indices.
IV. Statistical analysis
Survival was measured from the date of admission to that of death. The Kaplan-Meier method was used to estimate the survival distribution, and the generalized Wilcoxon method was used for comparisons. The correlations between the MIB-1 and PCNA proliferating cell indices and survival time were determined by linear regression analysis. The statistical significance of differences in MIB-1 and PCNA proliferating cell indices between histological grades and between clinical factors and survival time were determined by the t-test for unpaired data using Stat view IV statistical software (Abacus Concepts, Berkeley, Calif., U.S.A.). The statistical significance of differences between histological grades and tumor extension was determined by chi-square statistics.
Results
I. Histology and tumor extension
The original tumor location was estimated from The 40 autopsy cases were divided into four groups according to direct invasion and dissemination as shown in Fig. 2 . Glioblastoma grew within the brain stem with (type III, n ＝ 4) or without (type I, n ＝ 12) leptomeningeal dissemination. Glioblastoma spread beyond the brain stem with (type IV, n ＝ 8) or without (type II, n ＝ 10) subarachnoid seedings. Four anaplastic astrocytomas were type I and one was type II. The one astrocytoma showed type I growth. Supratentorial extension was more frequent in glioblastomas than in anaplastic astrocytomas (p º 0.05).
II. MIB-1 and PCNA staining
MIB-1 and PCNA immunohistochemistry ( Fig. 1 ) were evaluable in 25 of 38 cases and 33 of 38 cases, respectively. MIB-1 staining was not evaluable because of no nuclear staining (8 cases) or diffuse nonspecific cytoplasmic staining (5 cases). PCNA staining was not evaluable because of no nuclear staining (1 case) or diffuse nonspecific cytoplasmic staining (4 cases). These unevaluable cases were not obviously related to period of storage, period of brain death, period of fixation, fixation solution, interval from death to autopsy, or season of the autopsy. No inner positive control was examined.
MIB-1 proliferating cell index was 8.0-45.4%
(mean 20.4%) and PCNA proliferating cell index was 14.7-83.0% (mean 37.0%) for glioblastoma. The mean PCNA proliferating cell index was 10.8% for anaplastic astrocytoma, which was significantly lower than that of glioblastoma (p º 0.05). The MIB-1 and PCNA proliferating cell indices were 2.9% and 20.3%, respectively, for astrocytoma. PCNA staining showed a wide variety of staining density and sometimes the evaluation of positive or negative was not easily decided compared to MIB-1 staining. Positive PCNA staining was defined as strong nuclear staining or slightly weak staining limited absolutely to the nucleus.
III. Survival time and prognostic factors
Median survival was 40 weeks for patients with glioblastomas and 74 weeks for patients with anaplastic astrocytomas and astrocytoma in treated cases. One astrocytoma patient survived 56 weeks. There was a significant difference in survival time between glioblastomas and anaplastic astrocytomas or astrocytoma in treated cases (p º 0.05) (Fig. 3) . All patients except for a 7-year survivor were dead within 2 years and the overall median survival time was 32 weeks.
Patients with glioblastomas who underwent radiotherapy had a mean survival time of 41.0 weeks, which was significantly longer than that of patients who received no radiotherapy (mean survival time 9.3 weeks) (p º 0.05). Linear regression analysis showed no significant correlation between MIB-1 proliferating cell index and survival time (R ＝ -0.327, p ＝ 0.119).
Discussion
I. Histological characteristics of diffuse type brainstem glioma About two thirds of cases of diffuse type brainstem glioma were classified as high-grade glioma in autopsy studies. 6, 7, 20, 22, 23, 32, 33) In our study, high-grade glioma was found in 39 of 40 cases. The reported incidence of high-grade glioma in biopsy studies varies from 22% to 67%. 3, 21, 31, 36) The discrepancy between biopsy and autopsy studies is probably due to sampling error or histological heterogeneity. 2, 5, 6, 11, 36) In our study, half of the untreated early stage tumors showed histological heterogeneity as the central part of the tumors was more malignant and had more neovascularization than the periphery. These tumors were classified as glioblastoma because of the presence of some glioblastoma tissue, although most of the tumor tissues were classified as anaplastic astrocytoma or astrocytoma because of the absence of necrosis or microvascular proliferation. Therefore, we suggest that one of the histological characteristics of diffuse type brainstem gliomas is the presence of little necrosis or microvascular proliferation. We also suggest that most of these tumors progress rapidly and develop more malignant features until death (secondary glioblastoma). The other half of the untreated early stage tumors presented with typical histological findings of supratentorial glioblastoma, which included pseudopalisading and glomeruloid vascular proliferation in most of the tumor tissue (de novo glioblastoma). We think that the histological features of diffuse type brainstem gliomas are not uniform and several pathological types exist. Therefore, the incidence of high-grade glioma was higher than that of previous reports and biopsy specimens are likely to be classified as more benign than the true tumor grade.
Very few autopsy studies have investigated supratentorial and spinal extensions. Three cases each of direct supratentorial extension and direct spinal extension, and 10 cases of cerebellar extension were found among 23 cases at autopsy. 22) However, supratentorial extension was examined only in the temporal lobe. In our study, direct supratentorial extension was observed in 18 cases, cerebellar extension in 14 cases, and spinal extension in three cases. Therefore, supratentorial extension is relatively frequent. The incidence of the leptomeningeal dissemination evaluated at autopsy was reported as 17%, 17%, 33%, and 17%. [21] [22] [23] 29) In our large series, 13 cases of leptomeningeal dissemination were observed, an incidence as high as that of supratentorial glioblastoma, 28) and widespread subarachnoid dissemination was observed in six of these 13 cases. Therefore, we suggest that diffuse type brainstem glioma in the advanced stage is characterized by relatively frequent supratentorial extension and leptomeningeal dissemination.
II. Proliferative potentials and prognostic factors
There were significant differences in survival time between patients with glioblastomas and those with anaplastic astrocytomas and astrocytoma. The PCNA proliferating cell indices showed significant differences between glioblastomas and anaplastic astrocytomas, so the PCNA proliferating cell index is related to the biological malignancy of diffuse type brainstem glioma like other brain tumors. However, we could not evaluate the MIB-1 proliferating cell indices in the cases of anaplastic astrocytomas, so we could not find any significant differences between MIB-1 proliferating cell indices and histological grading. Also, there was no significant correlation between MIB-1 or PCNA proliferating cell index and patient survival time, although there was a slight correlation between MIB-1 proliferating cell index and survival time. These patients soon develop respiratory and swallowing disturbances and tetraplegia, and become bedridden with pneumonia, so the survival time is probably shortened by these complications. This study includes both old and recent cases, so the patient managements including operation and radiochemotherapy varied with individuals. These problems make the relationship between MIB-1 or PCNA proliferating cell index and survival time difficult to evaluate.
Radiotherapy obviously improved the prognosis but the effect of chemotherapy was not observed in this study. This study found that the mean MIB-1 proliferating cell index of glioblastomas was 20.4%, which is as high as that of adult supratentorial glioblastoma. 27, 30) We suggest that the proliferative potential of diffuse type brainstem gliomas is as high as that of adult supratentorial glioblastoma. 
